273 Views
Category: Bacteremia
Poster Session: Bacteremia
Aisling R. Caffrey
Director of Outcomes Research
1. Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States 2. Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States 3. College of Pharmacy, University of Rhode Island, Kingston, RI, United States 4. School of Public Health, Brown University, Providence, RI
Kingston, Rhode Island
Disclosure: Merck (Research Grant or Support)Pfizer (Research Grant or Support)Shionogi (Research Grant or Support)
Emily T. O'Neill
Infectious Diseases Post-Doctoral Fellow
1. Providence Veterans Affairs Medical Center, Providence, RI, United States 2. College of Pharmacy, University of Rhode Island, Kingston, RI, United States
Providence, Rhode Island
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Vrishali V. Lopes
Research Analyst
1. Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States
Providence, Rhode Island
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Erlinda R. Ulloa
Assistant Professor
University of California Irvine
San Diego, California
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
George Sakoulas
Associate Adjunct Professor
5. University of California, San Diego School of Medicine, La Jolla, CA, United States
La Jolla, California
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Victor Nizet
Distinguished Professor and Vice Chair
University of California San Diego
San Diego, CA
Disclosure: Centauri Therapeutics (Advisor or Review Panel member)Cidara Therapeutics (Advisor or Review Panel member)InhibRx (Advisor or Review Panel member)Roche Pharmaceutical (Advisor or Review Panel member)
Kerry L. LaPlante
Professor and Chair
1. Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, RI, United States 2. Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, RI, United States 3. College of Pharmacy, University of Rhode Island, Kingston, RI, United States 5. Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, RI
Kingston, Rhode Island
Disclosure: Merck (Advisor or Review Panel member, Research Grant or Support)Ocean Spray Cranberries, Inc. (Research Grant or Support)Pfizer Pharmaceuticals (Research Grant or Support)Shionogi, Inc. (Research Grant or Support)